Related by context. All words. (Click for frequent words.) 74 Sym# 74 PNP inhibitor 74 Phase #b/#a clinical 73 ALN TTR 73 Familial Adenomatous Polyposis FAP 73 phase IIb clinical 73 phase IIa clinical 73 PDE4 inhibitor 73 forodesine 73 AEG# 73 PEG SN# 72 Archexin 72 targeted radiotherapeutic 72 TBC# 72 Traficet EN 72 cannabinor 72 FOLOTYN ® 72 oral prodrug 72 histone deacetylase HDAC inhibitor 71 YONDELIS 71 depsipeptide 71 HQK 71 MAGE A3 ASCI 71 VitiGam 71 IMA# 71 Phase Ib study 71 Aviptadil 71 Phase IIb clinical trials 71 Fx #A 71 nucleoside analog 71 alvespimycin 71 R roscovitine 71 TG# [003] 71 anticancer compound 71 CB2 selective receptor agonist 71 Androxal TM 71 investigational humanized monoclonal antibody 71 ATL# [001] 71 lintuzumab SGN 71 Enzastaurin 71 Romidepsin 71 R#/MEM # 71 Fibrillex TM 71 Cloretazine 71 Azedra 71 SNT MC# 70 novel VDA molecule 70 mertansine 70 Panzem R NCD 70 IL# PE#QQR 70 Vidofludimus 70 RNAi therapeutic targeting 70 CA4P 70 Cloretazine ® 70 CYT# potent vascular disrupting 70 histone deacetylase inhibitor 70 Alzhemed TM 70 Cannabinor 70 Darinaparsin 70 fosbretabulin 70 ALN TTR# 70 Sapacitabine 70 TPI ASM8 70 non nucleoside inhibitor 70 vinca alkaloid 70 HuLuc# 70 MEK inhibitor 70 Proxinium TM 70 proteasome inhibitor 70 metaglidasen 70 Aflibercept 70 diarrhea predominant irritable 70 PSMA ADC 70 torezolid phosphate 70 Phase 1a clinical 70 CCX# 70 CBLC# 70 Tarvacin TM 70 Guanilib 70 Zenvia ™ 70 orally administered inhibitor 70 AQ4N 69 multicenter Phase II 69 PDX pralatrexate 69 JAK inhibitor 69 OMP #M# 69 Panzem R 69 receptor tyrosine kinase inhibitor 69 Exherin TM 69 pan HDAC inhibitor 69 Mipomersen 69 ATL# [002] 69 Pafuramidine 69 drug GLPG# 69 ADVANCE PD 69 seliciclib CYC# 69 Tyrima 69 HGS ETR1 mapatumumab 69 TELINTRA 69 Chemophase 69 OncoVEX GM CSF 69 Trofex 69 Phase Ib II 69 Annamycin 69 Phase Ib clinical 69 NP2 Enkephalin 69 Vidaza azacitidine 69 Cethrin R 69 Pimavanserin 69 ENMD # 69 Spiegelmer ® 69 Factor VIIa 69 huC# DM4 69 PRT# 69 CCR5 antagonist 69 investigational therapies 69 TRO# 69 phase IIb trial 69 Omacetaxine 69 selective androgen receptor modulator 69 INCB# [001] 69 IRX 2 69 intranasal formulation 69 Aplidin R 69 riociguat 69 Seliciclib 69 JAK2 inhibitor 69 HuMax CD4 69 ketolide antibiotic 69 Squalamine 69 Dacogen injection 69 OHR/AVR# 69 HCV polymerase 69 Safinamide 69 Denufosol 69 PHX# 69 GRNVAC1 69 lomitapide 69 Onalta 69 GW# [003] 69 Pathway Inhibitor 69 MGd 68 HCD# [002] 68 Bezielle 68 vascular disrupting agents 68 next generation URAT1 68 Phase #b/#a 68 angiogenesis inhibitor 68 investigational monoclonal antibody 68 Alocrest 68 DermaVir Patch 68 docetaxel Taxotere ® 68 NEUGENE 68 REP# 68 Iluvien ® 68 SUTENT ® 68 gastro intestinal inflammation 68 Nanobody 68 XL# XL# 68 subcutaneous formulation 68 ALN PCS 68 indibulin 68 HGS# 68 midstage trials 68 systemic RNAi therapeutic 68 TACI Ig 68 AAG geldanamycin analog 68 TÎ ² 4 68 ONCONASE R 68 Alinia 68 midstage clinical 68 Dalbavancin 68 small molecule Hedgehog 68 sorafenib Nexavar 68 anti CD3 antibody 68 tiapamil 68 Phenoptin 68 systemically administered 68 Pertuzumab 68 Aryplase 68 Solazed TM 68 generation purine nucleoside 68 MKC# MKC# PP 68 Maribavir 68 selective kinase inhibitor 68 mitogen activated ERK kinase 68 ELACYT 68 RhuDex ® 68 cutaneous T 68 kidney urologic 68 opioid induced bowel dysfunction 68 Onalta ™ 68 humanized anti 68 multi kinase inhibitor 68 rNAPc2 68 Microplasmin 68 CYT# 68 HCV protease inhibitor 68 TLR9 agonist 68 PSN# [002] 68 RNAi Therapeutic 68 Protexia ® 68 Gleevec resistant 68 phase IIa 68 radiation sensitizer 68 SinuNase ™ 68 Hsp# Inhibitor 68 PGL# 68 triphendiol 68 PLK1 SNALP 68 Amrubicin 68 novel peptide 68 ISTODAX 68 ospemifene 68 OvaRex ® MAb 68 MT#/MEDI-# 68 synthetic retinoid 68 Daclizumab 68 Amigal 68 Alfacell proprietary ribonuclease 68 HCV NS5B polymerase 68 PRTX 68 CR# vcMMAE 68 Phase IIa trial 68 Cloretazine R 68 JAK inhibitors 68 phase Ib clinical 68 Talabostat 68 ongoing Phase 1b 68 non nucleoside HCV 68 Virulizin ® 67 VNP#M 67 histone deacetylase HDAC inhibitors 67 orally bioavailable 67 antibody MAb 67 Initiates Phase II 67 Vandetanib 67 Sudhir Agrawal D.Phil 67 romidepsin 67 mGluR5 NAM 67 trastuzumab DM1 T DM1 67 MKC# MT 67 PF # [002] 67 vascular disrupting agent 67 therapeutic monoclonal antibody 67 rilonacept 67 rhIGF-I/rhIGFBP-3 67 Panzem 67 favorable pharmacokinetic profile 67 docetaxel Taxotere R 67 Diamyd ® 67 A3 adenosine receptor 67 Voreloxin 67 myelofibrosis polycythemia vera 67 metastatic castration resistant 67 eniluracil 67 velafermin 67 PORxin TM 67 CMV vaccine 67 Zalypsis 67 Liprotamase 67 lucinactant 67 Prodarsan ® 67 alkylating agent 67 Xanafide 67 AA amyloidosis 67 Dapagliflozin 67 inhibitor RG# 67 pharmacokinetic PK study 67 cell lymphoma CTCL 67 preclinically 67 VitiGam TM 67 microtubule inhibitor 67 SinuNase TM 67 mapatumumab 67 liposomal formulation 67 targeted antifolate 67 BrachySil TM 67 Phase IIa clinical 67 entinostat 67 PrevOnco 67 Myocet 67 JZP 67 GLP toxicology studies 67 protein kinase inhibitors 67 recurrent glioblastoma multiforme 67 candidate REP# 67 sodium thiosulfate STS 67 ganaxolone 67 Radezolid 67 Phase IIIb clinical 67 Lenocta 67 Azedra TM 67 IMiDs R 67 Hepatocellular Carcinoma HCC 67 PEGylated Fab fragment 67 KNS # 67 acetonide FA 67 BAY #-# 67 Phase 1b clinical trials 67 TLR antagonists 67 PDE# inhibitors 67 siRNA therapeutic 67 Ataluren 67 Tezampanel 67 Pyridorin 67 EOquin 67 OMP #R# 67 elotuzumab 67 Arimoclomol 67 neratinib 67 oral antiviral 67 inhaled liposomal ciprofloxacin 67 Aplidin 67 AP# [003] 67 Cethromycin 67 HDAC Inhibitor 67 tafamidis 67 brivaracetam 67 CCR5 mAb 67 dose escalation clinical 67 radiotherapeutic 67 ATL/TV# 67 HuMax EGFr 67 pafuramidine 67 Blinatumomab 67 Ceflatonin 67 LHRH receptor positive 67 Angiocept 67 Allovectin 7 R 67 humanized monoclonal 67 EGS# 67 tanespimycin 67 compound AEOL # 67 Immunotherapeutic 67 Phase Ib clinical trials 67 NS5A 67 IAP inhibitor 67 topically administered 67 polysaccharide polymer 67 IgG1 antibody 67 Shigamabs ® 67 Allovectin 7 67 Tesetaxel 67 Diabetic Macular Edema DME 67 Soliris eculizumab 67 Enzyme Replacement Therapy 67 Lisofylline LSF 67 Phase IIa trials 67 Phase Ib IIa 67 hyperphenylalaninemia HPA due 67 LEP ETU 67 Elesclomol 67 HGS ETR1 67 DOS# 67 therapeutic monoclonal antibodies 67 ELND# 67 ganetespib 67 Pivotal Phase III 67 Therapeutic Vaccine 67 Plicera 67 PrevOnco ™ 67 GLPG# 66 MEK inhibitors 66 #D#C# 66 sorafenib tablets 66 Aurexis 66 Vicinium TM 66 IgG1 monoclonal antibody 66 PD LID 66 Ramoplanin 66 Aganocide 66 Tarceva TM 66 posaconazole 66 immunotherapeutic vaccine 66 LAB CGRP 66 AKT inhibitor 66 Triolex 66 non nucleoside 66 aurora kinase 66 Cetrorelix 66 engineered RAP peptides 66 telomerase therapeutic 66 obatoclax 66 Phase Ib 66 ThermoDox R 66 PKC# 66 metastatic neuroendocrine tumors 66 Carfilzomib 66 somatostatin analogue 66 talabostat 66 Solazed 66 YONDELIS R 66 EVIZON TM 66 Anidulafungin 66 preclinical efficacy 66 GAMMAGARD 66 NS5b 66 TLK# 66 monoclonal antibody conjugated 66 Cerebril TM 66 SAR# [002] 66 refractory gout 66 NPC 1C 66 NOX E# 66 molecular imaging radiopharmaceutical 66 Luteinizing Hormone Releasing Hormone 66 Genasense ® oblimersen 66 thymalfasin 66 Symadex 66 Zenvia Phase III 66 DDP# 66 Personalized Immunotherapy 66 SCH # 66 BRIM2 66 refractory chronic lymphocytic 66 AN# novel 66 cMET 66 pertuzumab 66 Ozarelix 66 histone deacetylase HDAC 66 Golimumab 66 NEUMUNE 66 Cardio Vascu Grow 66 Chemokine Receptor 66 Ocrelizumab 66 THR beta agonist 66 CRD5 66 romidepsin novel 66 Kamada AAT 66 CDP# 66 Methylnaltrexone 66 antisense inhibitors 66 chemotherapy induced neutropenia 66 OncoVex 66 metastatic hormone refractory 66 immunotherapeutic agent 66 Chemokine 66 OvaRex R 66 Pegloticase 66 Asentar 66 chimeric monoclonal antibody 66 Multiple Ascending Dose 66 Elocalcitol 66 CORT # 66 JAK3 66 flavopiridol 66 teriflunomide 66 virus HCV protease inhibitor 66 BrachySil 66 HGS ETR2 66 Proellex TM 66 rxRNA 66 Glufosfamide 66 GAP #B# 66 oral ridaforolimus 66 trial evaluating PRX# 66 #I TM# 66 tubulin inhibitor 66 recombinant subunit vaccine 66 KRN# 66 protein kinase inhibitor 66 OMNARIS HFA 66 acyclovir Lauriad R 66 LymphoStat B TM 66 novel oral anticoagulant 66 intravesical instillation 66 demonstrated antitumor activity 66 Elagolix 66 familial amyloidotic polyneuropathy FAP 66 CD# CEA 66 M2 subunit 66 Phase 2a clinical 66 drug ISA# 66 Curaxin CBLC# 66 Zybrestat 66 NTDDS 66 GSK# [002] 66 tezampanel NGX# 66 ASONEP 66 Homspera TM 66 DAVANAT 66 Trofex TM 66 Velcade bortezomib 66 investigational hepatitis C 66 Protexia R 66 REGN# 66 Aliskiren 66 polycythemia vera essential thrombocythemia 66 levodopa induced dyskinesia 66 HCV protease inhibitors 66 CTAP# Capsules 66 PROVENGE sipuleucel T 66 Zemiva TM 66 Aurora kinase inhibitor 66 Cloretazine R VNP#M 66 selective modulator 66 PhG alpha 1 66 volociximab 66 teplizumab 66 Aclidinium 66 Vascugel 66 GATTEX TM 66 Pharmacokinetics PK 66 compound AEZS 66 Litx 66 Deforolimus 66 non alcoholic steatohepatitis 66 cysteamine bitartrate 66 tolevamer 66 Kahalalide F 66 evaluating tivozanib 66 Phase 2b Clinical Trial 66 ALV# 66 BCR ABL inhibitors 66 Temsirolimus 66 delivers fluocinolone acetonide FA 66 pafuramidine maleate 66 apoptosis inducer 66 PI3K inhibitor 66 reslizumab 66 PNT# 66 TKB# 66 Phase III Pivotal 66 LUMINATE 66 Triapine 66 Nanobody ® 66 Apaziquone 66 novel anticancer 66 vidofludimus 66 OncoVEX 66 adecatumumab MT# 66 EZN 66 rhMBL 66 novel prodrug 66 IAP inhibitors 66 BENLYSTA ® 66 zanolimumab 66 thalidomide Thalomid 66 budesonide foam 66 EndoTAG TM -1 66 Atiprimod 66 hypoxia activated prodrug 66 IMiDs ® 66 Ridaforolimus 66 mGluR2 NAM 66 CHAMPION PCI 66 Civacir 66 REG2 66 dasatinib Sprycel ® 66 myeloproliferative disorders 66 RGB # 66 APEX PD 66 ISF# 66 Phase 2b clinical trials 66 novel therapeutic antibodies 66 BiTE 66 acadesine 66 bevacizumab Avastin ® 66 Exelixis XL# 66 XmAb# 66 cyclophilin inhibitors 66 ALK inhibitor 66 synthetic siRNA 66 PEGPH# 66 humanized antibody 66 histamine dihydrochloride 66 Dacogen decitabine 66 TKM ApoB 66 G#DT 66 ORMD 66 daptomycin 66 faropenem 66 NXL# 66 CRLX# 66 Laquinimod 66 targeting CD# 66 LHRH antagonist 65 Afatinib 65 Onalta TM 65 Glypromate 65 dermal patch 65 busulfan 65 octreotide implant 65 Familial Adenomatous Polyposis 65 phase Ib 65 Rilonacept 65 Epratuzumab 65 Excellarate TM 65 confirmatory Phase III 65 eprotirome 65 INCB# [003] 65 DermaVir 65 P#X# 65 uricase 65 INSPIRE Trial Phase III 65 Onconase 65 Raptiva R 65 cilengitide 65 p# inhibitor 65 mTOR mammalian target 65 Anticalin R 65 PANVAC VF 65 Tanespimycin 65 JAK1 65 epothilone 65 oral Janus kinase 65 Tesmilifene 65 ALS #-# 65 targeting PCSK9 65 ASM8 65 PEG uricase 65 Ophena TM 65 paclitaxel poliglumex 65 selective inhibition 65 recurrent glioma 65 Pazopanib 65 DEB# 65 transthyretin TTR mediated amyloidosis 65 CD# monoclonal antibody 65 GVAX ® 65 Silodosin 65 Lixivaptan 65 drug GAP #B# 65 either acutely decompensated 65 ocular formulation 65 sitaxsentan 65 farletuzumab 65 Dasatinib 65 tezampanel 65 PEGylated interferon beta 1a 65 phase IIb 65 Preclinical studies suggest 65 PEGylated 65 OXi# 65 Acute Radiation Syndrome ARS 65 MT# MEDI 65 Anturol TM 65 dextofisopam 65 nucleotide analog 65 ulimorelin 65 atacicept 65 AZX# 65 ruxolitinib 65 QLT# 65 ADAMTS# 65 efalizumab 65 relapsed MM 65 mTOR inhibitor 65 DiLA2 65 Pralatrexate 65 immunological diseases 65 drug conjugate 65 Initiates Enrollment 65 anticoagulant reversing agent 65 Onrigin 65 Protectan CBLB# 65 Aurora kinase 65 oncolytic virus therapy 65 TheraCIM 65 IMC #B 65 Cloretazine VNP#M 65 Oral NKTR 65 ILUVIEN ® 65 MAP# 65 DB# [003] 65 orally dosed 65 Kinase Inhibitor 65 BiTE antibody 65 novel histone deacetylase 65 lexidronam injection 65 RhuDex 65 RhuDex R 65 Urocidin TM 65 prokinetic agent 65 nucleotide analogue 65 anticancer therapeutics 65 castrate resistant prostate cancer 65 candidate TNFerade biologic 65 Ecallantide 65 Curaxin 65 p# biomarker 65 investigational drug 65 investigational pan BCR 65 Tyrosine Kinase Inhibitor 65 oropharyngeal candidiasis 65 Clevudine 65 ALN VSP 65 2 methoxyestradiol 65 AVE# 65 Hedgehog pathway inhibitor 65 HDL Mimetic Peptide 65 cancer immunotherapies 65 MOZOBIL 65 XL# XL# XL# 65 Prodarsan R 65 Tß4 65 huN# DM1 65 intravenous methylnaltrexone 65 alefacept 65 DCVax R 65 trastuzumab Herceptin ® 65 oral picoplatin 65 long acting muscarinic 65 Prodarsan 65 Altastaph 65 bortezomib Velcade 65 Phase 2a trial 65 oral methylnaltrexone 65 rhITF 65 Phase 2a clinical trials 65 Anticalin ® 65 injectable investigational 65 compound INCB# 65 Evoltra ® 65 Genasense ® 65 randomized Phase IIb 65 including eniluracil ADH 65 ALN HPN 65 XL# XL# XL# XL# 65 oral proteasome inhibitor 65 oncolytic vaccine 65 Zolinza 65 orBec 65 anti secretory 65 ZYBRESTAT fosbretabulin 65 BCX# 65 oral JAK#/JAK# inhibitor 65 HSP# inhibitor 65 peripherally acting 65 humanized monoclonal antibodies 65 Friedreich Ataxia FRDA 65 Lubiprostone 65 Hepatitis C virus HCV 65 immatics 65 Cimzia ® certolizumab pegol 65 ularitide 65 erlotinib Tarceva ® 65 BioNumerik 65 Ceflatonin R 65 polymerase inhibitor 65 Fodosine 65 Corlux 65 INS# [001] 65 relapsed leukemia 65 Saforis 65 tramiprosate 65 luliconazole 65 Nicole Onetto MD 65 Unit Dose Budesonide 65 molecular chaperone regulator 65 orally inhaled migraine 65 methylnaltrexone bromide 65 Interferon alpha 65 Teriflunomide 65 SERMs 65 metastatic colorectal 65 DXL# 65 antagomirs 65 Granulocyte Colony Stimulating Factor 65 MVA BN R 65 Eculizumab 65 dyskinesia PD LID 65 MAXY G# 65 octreotide acetate 65 PDE4 65 Muraglitazar 65 Telbivudine 65 Amplimexon 65 calcineurin inhibitor 65 PCK# 65 pharmacokinetic PK 65 Uricase PEG 65 BRAF inhibitor 65 ZOLINZA 65 Bazedoxifene 65 lumiliximab 65 Davanat 65 dexanabinol 65 dacetuzumab 65 small molecule glucokinase 65 Gamunex C 65 rPA anthrax vaccine 65 lorvotuzumab mertansine 65 NV1FGF 65 LibiGel ® 65 essential thrombocythemia ET 65 Phase 2b trial 65 sodium Injection 65 Kuvan TM sapropterin 65 Raptiva ® 65 Phase 1b clinical 65 Pancreate 65 Nitazoxanide 65 JAK2 Inhibitor 65 Tolvaptan 65 ART# 65 Elotuzumab 65 Melphalan 65 tigecycline 65 dextromethorphan quinidine 65 HepeX B TM 65 generation Hsp# inhibitor 65 CG# [003] 65 immunomodulatory therapy 65 Nimotuzumab 65 HoFH 65 cetuximab Erbitux R 65 CINOD 65 Valortim ® 65 solithromycin 65 Irinotecan 65 NS#/#A protease 65 Androxal ® 65 RiVax 65 superficial bladder cancer 65 humanized monoclonal antibody 65 generation URAT1 inhibitor 65 toenail onychomycosis 65 Phase IIb III 64 immune modulator 64 registrational 64 Epidermal Growth Factor Receptor 64 blinded randomized placebo controlled 64 ocrelizumab 64 Presents Preclinical Data 64 nanopharmaceutical 64 BrachySil ™ 64 accumulate preferentially 64 radezolid 64 cetuximab Erbitux ® 64 erythropoietic 64 Investigational Treatment 64 BZL# 64 Small Molecule 64 Panzem NCD 64 small molecule thrombopoietin 64 beta 1a 64 Junovan TM 64 Liposomal 64 Saxagliptin 64 radiolabeled monoclonal antibody 64 RDEA# 64 inhaled AAT 64 refractory prostate cancer 64 Removab 64 Phase IIb clinical 64 Alvesco R 64 MAXY VII 64 alemtuzumab Campath 64 Chrysalin 64 K ras mutations 64 Randomized Double blind 64 PXD# 64 forodesine hydrochloride 64 TOCOSOL Camptothecin 64 omacetaxine mepesuccinate 64 ACV1 64 humanised antibody 64 phase III isavuconazole 64 Forodesine HCl 64 anti amnesic 64 adenosine A2A 64 Bucindolol 64 XYOTAX TM 64 LUVENIQ 64 chemically modified siRNA 64 malignant ascites 64 TELINTRA R 64 Valortim R 64 Insegia 64 diabetic neuropathic pain 64 Myelodysplastic Syndrome MDS 64 Reports Preclinical Data 64 Tarvacin 64 hyaluronidase enzyme 64 isoform selective 64 HuMax TAC 64 aflibercept VEGF Trap 64 Excellarate 64 monoclonal anti 64 renin inhibitor 64 hypereosinophilic syndrome 64 rALLy clinical trial 64 Tarmogen 64 glucagon receptor 64 Darusentan 64 ZYBRESTAT 64 SCIB1 64 Belimumab 64 HDL Selective Delipidation 64 advanced carcinoid 64 ara C 64 Phase 2a Clinical Trial 64 2 inhibitor CYT# 64 Triapine R 64 MCSP respectively 64 menadione 64 chemokine receptor 64 pharmacological chaperone 64 sulodexide 64 Crizotinib 64 HDACi 64 apricitabine ATC 64 combretastatin A4 phosphate CA4P 64 gemcitabine Gemzar ® 64 BAL# [002] 64 Phase #b/#a trial 64 delafloxacin 64 MAXY alpha 64 incyclinide 64 alagebrium 64 Sphingomab TM 64 glucokinase activator 64 tramiprosate Alzhemed TM 64 PEG PAL 64 cetrorelix pamoate 64 antisense inhibitor 64 RLY# 64 Bicifadine 64 VAPRISOL 64 methylnaltrexone 64 VA# [002] 64 Chimigen TM 64 Solazed ™ 64 ARIKACE ™ 64 SAR# [004] 64 Phase IIB 64 phase IIb study 64 thorough QT 64 Nexavar sorafenib 64 CCR9 antagonist 64 lesinurad 64 apricitabine 64 UPLYSO 64 epothilones 64 thetreatment 64 adalimumab Humira 64 EcoNail 64 IMiDs ® compound 64 interleukin IL -# 64 Erbitux cetuximab 64 postoperative ileus 64 oral salmon calcitonin 64 Azacitidine 64 Phase #/#a trial 64 teduglutide 64 pomalidomide 64 topically applied SEPA 64 Nexavar ® 64 CDDO Im 64 NSCLC tumors 64 StemEx R 64 TLR9 agonists 64 PEGylated anti 64 BNC# 64 Etubics 64 Intravenous CP 64 DACH platinum 64 Dyloject TM 64 H#N# VLP vaccine 64 Medidur TM FA 64 RNA antagonists 64 Urocidin 64 highly selective inhibitor 64 GATTEX ® 64 Kinoid 64 Peginterferon alfa 2b 64 BXT # 64 6R BH4 64 tkRNAi 64 Lu AA# 64 Posiphen TM 64 rBChE 64 polycythemia vera PV 64 polymerase inhibitors 64 Zerenex 64 monoclonal antibody MAb 64 advanced metastatic renal 64 selective antagonist 64 CINTREDEKIN BESUDOTOX 64 GALNS 64 antisense drug 64 TKM Ebola 64 effector function 64 ProLindac TM 64 Randomized Phase 64 alvimopan 64 ORE# 64 Degarelix 64 HepeX B 64 sapacitabine CYC# 64 TASKi3 64 chemopreventive agent 64 Initiate Phase 64 Initiates Clinical 64 Pyridorin TM 64 Bavituximab 64 BRIM3